612 related articles for article (PubMed ID: 36781138)
1. Zebrafish-based platform for emerging bio-contaminants and virus inactivation research.
Patel P; Nandi A; Verma SK; Kaushik N; Suar M; Choi EH; Kaushik NK
Sci Total Environ; 2023 May; 872():162197. PubMed ID: 36781138
[TBL] [Abstract][Full Text] [Related]
2. Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development.
Huang SW; Tai CH; Hsu YM; Cheng D; Hung SJ; Chai KM; Wang YF; Wang JR
Biomed J; 2020 Aug; 43(4):375-387. PubMed ID: 32611537
[TBL] [Abstract][Full Text] [Related]
3. Transchromosomic bovines-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1, and influenza A virus.
Saied AA; Nascimento MSL; do Nascimento Rangel AH; Skowron K; Grudlewska-Buda K; Dhama K; Shah J; Abdeen A; El-Mayet FS; Ahmed H; Metwally AA
J Med Virol; 2022 Oct; 94(10):4599-4610. PubMed ID: 35655326
[TBL] [Abstract][Full Text] [Related]
4. Addressing the Threat of Emerging Viral Infections.
Kawaoka Y
Keio J Med; 2023; 72(1):27. PubMed ID: 36967128
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.
Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM
J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and Transmission Assessments of Two H7N8 Influenza A Viruses Recently Isolated from Turkey Farms in Indiana Using Mouse and Ferret Models.
Sun X; Belser JA; Pulit-Penaloza JA; Zeng H; Lewis A; Shieh WJ; Tumpey TM; Maines TR
J Virol; 2016 Dec; 90(23):10936-10944. PubMed ID: 27681133
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
8. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us.
Kumar V
Int Rev Immunol; 2021; 40(1-2):5-53. PubMed ID: 32744465
[TBL] [Abstract][Full Text] [Related]
9. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
Elife; 2022 May; 11():. PubMed ID: 35587653
[TBL] [Abstract][Full Text] [Related]
10. Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses.
Sperk M; van Domselaar R; Rodriguez JE; Mikaeloff F; Sá Vinhas B; Saccon E; Sönnerborg A; Singh K; Gupta S; Végvári Á; Neogi U
J Proteome Res; 2020 Nov; 19(11):4259-4274. PubMed ID: 33095583
[TBL] [Abstract][Full Text] [Related]
11. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X
J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551
[TBL] [Abstract][Full Text] [Related]
12. Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets.
Belser JA; Sun X; Kieran TJ; Brock N; Pulit-Penaloza JA; Pappas C; Basu Thakur P; Jones J; Wentworth DE; Zhou B; Tumpey TM; Maines TR
J Virol; 2022 Dec; 96(24):e0140322. PubMed ID: 36448801
[TBL] [Abstract][Full Text] [Related]
13. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.].
Lvov DK; Alkhovsky SV; Kolobukhina LV; Burtseva EI
Vopr Virusol; 2020; 65(1):6-15. PubMed ID: 32496715
[TBL] [Abstract][Full Text] [Related]
14. Co-circulation of coronavirus and avian influenza virus in wild birds in Shanghai (2020-2021).
Ma M; Ji L; Ming L; Xu Y; Zhao C; Wang T; He G
Transbound Emerg Dis; 2022 Nov; 69(6):3985-3991. PubMed ID: 36054919
[TBL] [Abstract][Full Text] [Related]
15. A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice.
Cao K; Wang X; Peng H; Ding L; Wang X; Hu Y; Dong L; Yang T; Hong X; Xing M; Li D; Zhu C; He X; Zhao C; Zhao P; Zhou D; Zhang X; Xu J
J Virol; 2022 Feb; 96(4):e0157821. PubMed ID: 34908443
[TBL] [Abstract][Full Text] [Related]
16. Stability of SARS-CoV-2 and other airborne viruses under different stress conditions.
Fumagalli MJ; Capato CF; de Castro-Jorge LA; de Souza WM; Arruda E; Figueiredo LTM
Arch Virol; 2022 Jan; 167(1):183-187. PubMed ID: 34727217
[TBL] [Abstract][Full Text] [Related]
17. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
Lvov DK; Alkhovsky SV
Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
[TBL] [Abstract][Full Text] [Related]
18. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
19. Effects of Non-Pharmacological Interventions on Respiratory Viruses Other Than SARS-CoV-2: Analysis of Laboratory Surveillance and Literature Review From 2018 to 2021.
Shi HJ; Kim NY; Eom SA; Kim-Jeon MD; Oh SS; Moon BS; Kwon MJ; Eom JS
J Korean Med Sci; 2022 May; 37(21):e172. PubMed ID: 35638198
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings.
Widera M; Westhaus S; Rabenau HF; Hoehl S; Bojkova D; Cinatl J; Ciesek S
Med Microbiol Immunol; 2021 Aug; 210(4):235-244. PubMed ID: 34196781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
